For example, the additional driver mutation could be the mutation activating the KRAS/BRAF pathway in a small colorectal adenoma, associated with the transformation from small to large adenoma, or the mutation that transforms benign adenoma into infiltrating carcinoma (Jones et al. 2008a). The gene discussed is KRAS; the disease is adenoma.